RxSight (RXST) Change in Accured Expenses (2020 - 2026)

RxSight's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at -$1.3 million for Q1 2026.

• Quarterly Change in Accured Expenses rose 79.64% year-over-year to -$1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (down 11.91% YoY) and the FY2025 annual result came in at -$1.9 million, down 131.95% from the prior year.
• Change in Accured Expenses was -$1.3 million for Q1 2026 at RxSight, down from $1.7 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $3.7 million in Q3 2024 and bottomed at -$6.2 million in Q1 2025.
• A 5-year average of $580352.9 and a median of $1.6 million in 2025 frame the typical range for Change in Accured Expenses.
• Peak annual rise in Change in Accured Expenses reached 91.9% in 2022, while the deepest fall reached 191.16% in 2022.
• RxSight's Change in Accured Expenses stood at $2.4 million in 2022, then decreased by 9.52% to $2.2 million in 2023, then surged by 58.72% to $3.5 million in 2024, then slumped by 51.26% to $1.7 million in 2025, then tumbled by 173.91% to -$1.3 million in 2026.
• Business Quant data shows RXST's Change in Accured Expenses at -$1.3 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.